A Phase I/II Study of High-Dose Tamoxifen in Combination with Vinblastine in Patients with Androgen-Independent Prostate Cancer

By Hamilton Michael   Dahut William   Brawley Otis   Davis Patricia   Wells-jones Toni   Kohler David   Duray Paul   Liewehr David J.   Lakhani Nehal   Steinberg Seth M.   Figg William D.   Reed Eddie  

Acta Oncologica, Vol. 42, Iss. 3, 2003-01 ,pp. : 195-201

Informa Healthcare

Access to resources Recommend Favorite

Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancer

By Beer T.M.   Eilers K.M.   Garzotto M.   Egorin M.J.   Lowe B.A.   Henner W.D.   Hsieh J.T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 4, 2003-07 ,pp. : 314-315

Elsevier

Access to resources Recommend Favorite

Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer?

By Nguyen K.H.   Horwitz E.M.   Hanlon A.L.   Uzzo R.G.   Pollack A.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 2, 2003-10 ,pp. : 377-383

Elsevier

Access to resources Recommend Favorite

Living alone, obesity and smoking: Important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer

By Dieperink Karin B.   Hansen Steinbjørn   Wagner Lis   Johansen Christoffer   Andersen Klaus K.   Hansen Olfred  

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 722-729

Informa Healthcare

Access to resources Recommend Favorite

The role of hemoglobin concentration in clinically localized prostate cancer treated with radical radiotherapy +/- neoadjuvant androgen deprivation

By Parker C.   Warde P.   Norman A.   Panzarella T.   Catton C.   Horwich A.   Huddart R.   Dearnaley D.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 53-58

Elsevier

Access to resources Recommend Favorite